Role of adenosine in status epilepticus: A potential new target?

Epilepsia

Volumn 54, Issue SUPPL. 6, 2013, Pages 20-22

  Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

Adenosine; Adenosine augmentation therapy; Adenosine kinase; Epigenetics; Neurogenesis

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE KINASE;

ANTICONVULSANT ACTIVITY; ARTICLE; DISEASE SEVERITY; ENZYME INHIBITION; EPIGENETICS; EPILEPTIC STATE; EPILEPTOGENESIS; GENE OVEREXPRESSION; GENE SILENCING; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; TRANSGENICS; ANIMAL; ASTROCYTE; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; STATUS EPILEPTICUS; ADENOSINE AUGMENTATION THERAPY; REVIEW;

ADENOSINE; ADENOSINE KINASE; ANIMALS; ASTROCYTES; HUMANS; STATUS EPILEPTICUS;

ADENOSINE; ADENOSINE AUGMENTATION THERAPY; ADENOSINE KINASE; EPIGENETICS; NEUROGENESIS;

EID: 84888403151     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12268     Document Type: Article

References (24)

1. Annes JP, Ryu JH, Lam K, Carolan PJ, Utz K, Hollister-Lock J, Arvanites AC, Rubin LL, Weir G, Melton DA. (2012) Adenosine kinase inhibition selectively promotes rodent and porcine islet betacell replication. Proc Natl Acad Sci U S A 109:3915-3920.
2. Aronica E, Sandau US, Iyer A, Boison D. (2013) Glial adenosine kinase-a neuropathological marker of the epileptic brain. Neurochem Int Feb 4 [Epub ahead of print].
3. Boison D. (2009) Adenosine augmentation therapies (aats) for epilepsy: Prospect of cell and gene therapies. Epilepsy Res 85:131-141.
4. Boison D. (2010) Inhibitory rna in epilepsy: Research tool and therapeutic perspectives. Epilepsia 51:1659-1668.
5. Boison D. (2012) Adenosine dysfunction in epilepsy. Glia 60:1234-1243.
6. Boison D. (2013) Adenosine kinase: Exploitation for therapeutic gain. Pharmacol Rev 65:906-943 in press.
7. Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, Brandner S, Mohler H. (2002) Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci USA 99:6985-6990.
8. Boison D, Masino MA, Geiger JD. (2011) Homeostatic bioenergetic network regulation-a novel concept to avoid pharmacoresistance in epilepsy. Expert Opin Drug Discov 6:713-724.
9. Clark RS, Carcillo JA, Kochanek PM, Obrist WD, Jackson EK, Mi Z, Wisneiwski SR, Bell MJ, Marion DW. (1997) Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery, 41:1284-1292; discussion 1292-1293.
10. Diógenes MJ, Neves-Tomé R, Fucile S, Martinello K, Scianni M, Theofilas P, Lopatar J, Ribeiro JA, Maggi L, Frenguelli BG, Limatola C, Boison D, Sebastiao AM. (2012) Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase. Cereb Cortex, Sep 20 [Epub ahead of print].
11. Dunwiddie TV, Masino SA. (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55.
12. Dworak M, Diel P, Voss S, Hollmann W, Struder HK. (2007) Intense exercise increases adenosine concentrations in rat brain: Implications for a homeostatic sleep drive. Neuroscience 150:789-795.
13. Fassett JT, Hu X, Xu X, Lu Z, Zhang P, Chen Y, Bache RJ. (2011) Adenosine kinase regulation of cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol 300:H1722-H1732.
14. Fredholm BB, Ijzerman AP, Jacobson KA, Linden J, Muller CE. (2011) International union of basic and clinical pharmacology. Lxxxi. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63:1-34.
15. Gouder N, Fritschy JM, Boison D. (2003) Seizure suppression by adenosine a1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44:877-885.
16. Gouder N, Scheurer L, Fritschy J-M, Boison D. (2004) Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 24:692-701.
17. Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, Itohara S, Simon RP, Boison D. (2008) Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Inv, 118:571-582; PMCID: PMC2157568.
18. Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, Geiger JD, Aronica E, Boison D. (2011) A ketogenic diet suppresses seizures in mice through adenosine a1 receptors. J Clin Inv 121:2679-2683.
19. Parent JM. (2007) Adult neurogenesis in the intact and epileptic dentate gyrus. Prog Brain Res 163:529-540.
20. Parent JM, Lowenstein DH. (2002) Seizure-induced neurogenesis: Are more new neurons good for an adult brain? Prog Brain Res 135:121-131.
21. Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D. (2007) Lentiviral rnai-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: A novel perspective for seizure control. Exp Neurol 208:26-37.
22. Shen HY, Lusardi TA, Williams-Karnesky RL, Lan JQ, Poulsen DJ, Boison D. (2011) Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab, 31:1648-1659; PMCID: PMC3137468.
23. Studer FE, Fedele DE, Marowsky A, Schwerdel C, Wernli K, Vogt K, Fritschy JM, Boison D. (2006) Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 142:125-137.
24. Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D. (2013) Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest Jul 25 [Epub ahead of print].